|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/60 | (2017.01) |
| A61K 47/60 | (2017.08) | ||
| A61K 47/64 | (2017.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 47/6903 | (2017.08) | ||
| A61K 47/69 | (2017.01) |
| (11) | Patento numeris | 2906246 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13774165.8 |
| Europos patento paraiškos padavimo data | 2013-10-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-07-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/070959 |
| Data | 2013-10-08 |
| (87) | Numeris | WO 2014/056923 |
| Data | 2014-04-17 |
| (30) | Numeris | Data | Šalis |
| 12188226 | 2012-10-11 | EP |
| (72) |
RAU, Harald , DE
KNAPPE, Thomas , DE
LAUFER, Burkhardt , DE
REIMANN, Romy , DE
WEISBROD, Samuel , DE
SPROGØE, Kennett , DK
BISEK, Nicola , DE
STARK, Sebastian , DE
VOIGT, Tobias , DE
|
| (73) |
Ascendis Pharma Ophthalmology Division A/S ,
Tuborg Boulevard 12, 2900 Hellerup,
DK
|
| (54) | VEGF NEUTRALIZING PRODRUGS COMPRISING RANIBIZUMAB FOR THE TREATMENT OF OCULAR CONDITIONS CHARACTERIZED BY OCULAR NEOVASCULARIZATION |
| VEGF NEUTRALIZING PRODRUGS COMPRISING RANIBIZUMAB FOR THE TREATMENT OF OCULAR CONDITIONS CHARACTERIZED BY OCULAR NEOVASCULARIZATION |